InsiderTrades

Form 4 for TER Teradyne

Accepted 2024-05-07 00:00:00 ET · period of report 2024-05-03 · accession 0000904454-24-000271 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-05-07 2024-05-03 TER Mehta Sanjay VP, CFO M - OptEx $72.10 +3,750 45.7K +9% +$270.4K
D 2024-05-07 2024-05-03 TER Mehta Sanjay VP, CFO S - Sale+OE $120.06 -3,750 41.9K -8% -$450.2K
D 2024-05-07 2024-05-03 TER Mehta Sanjay VP, CFO M - OptEx $0.00 -3,750 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-05-03 M A 3,750 $72.10 45,652.34 D — —
2 Common Common Stock 2024-05-03 S D 3,750 $120.06 41,902.34 D — —
3 Derivative Stock Option (Right to Buy) 2024-05-03 M D 3,750 $0.00 0 D $72.10 · — to 2027-01-24 3,750 Common Stock (F2) This option was granted under the Issuer's 2006 Equity and Cash Compensation Incentive Plan, and became exercisable at the rate of 25% per year commencing on January 24, 2021, the first anniversary of the grant.